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Where are we in the battle of 
ending tuberculosis in children and 
adolescents in South Africa?
To the Editor: Ambitious targets to end tuberculosis (TB) were 
set at the United Nations General Assembly High-Level Meeting 
(UNHLM) on TB in September 2018, with children and adolescents 
specifically noted as key populations deserving of more attention. [1] In 
addition, the World Health Organization (WHO) launched a revised 
‘Roadmap towards ending TB in children and adolescents’,[2] outlining 
key actions that should be taken at country level to engage relevant 
stakeholders to optimally prevent and treat TB in these age groups.
In South Africa (SA), paediatric TB notifications (<15 years) 
declined steeply between 2015 and 2017 (29 137 in 2015, 20 546 in 
2016 and 15 628 in 2017).[3] This fall could be due either to a true 
decline in cases or to a smaller proportion of cases being found. In 
2018, SA reported 17 561 cases to the WHO,[3] a 12% increase from 
2017 and probably due to the national ‘finding the missing TB cases 
campaign’ that was implemented in SA in 2018.
The WHO uses mathematical modelling to estimate the TB 
burden at both global and national level. In 2018, the WHO 
estimated that 27 000 children (<15 years; 95% confidence interval 
18 000 - 36 000) developed TB in SA.[3] Despite the 2018 increase in 
notifications, these estimates suggest that the SA childhood TB case 
detection rate is still only 65%, leaving a third of children with TB 
in SA undiagnosed or unreported.
At the UNHLM, SA committed to diagnose and treat 95 500 
children between 2018 and 2022 (Fig. 1).[4] Although SA achieved 
96% of its target for 2018, services will need to be strengthened 
if it is to keep up with these commitments and improve case 
detection. To achieve this, the country will need better diagnostics 
for young children, non-invasive and point-of-care microbiological 
sampling and testing for all children, and more training to empower 
healthcare workers to make clinical diagnoses. Following diagnosis, 
it is also essential to ensure accurate and complete reporting of all 
cases. Sub-national analyses of routine TB data can additionally 
provide information on where interventions are most needed.
TB preventive therapy (TPT) is a safe and effective strategy to prevent 
TB disease in children following exposure.[5] At the UNHLM, SA 
committed to provide TPT to 206 510 child contacts aged <5 years.[4] 
SA is shortly to roll out shorter TPT regimens, and if this approach 
is coupled with strengthened TB contact management and PT 
implementation,[6] it could drastically reduce the burden of TB 
disease among children and adolescents.
The lack of surveillance data on adolescents (10 - 19 years) with 
TB remains a concern. Despite being recognised as a vulnerable 
group, they are ‘missing’ in the age bands currently reported, 
being included either with children in the 5 - 14-year age band 
or with adults in the 15 - 24-year age band.[7] SA has a strong 
TB surveillance system, allowing age-disaggregated reporting at 
a much more granular level. The country should either revise 
the current age bands or report adolescents separately if service 
provision to this age group is to be evaluated properly.
On 24 March, we commemorated World TB Day. Each year, 
this represents an opportunity to reflect on the promises made 
for children and adolescents, to evaluate progress, and to identify 
future priorities.
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Fig. 1. National paediatric (<15 years) TB case notifications, WHO burden 
of disease estimates and committed UNHLM paediatric TB diagnosis and 
treatment targets for South Africa. (TB = tuberculosis; WHO = World 
Health Organization; UNHLM = United Nations General Assembly High-
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